SBRA Stock Analysis: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$18.73
0.21 (1.13%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
18d
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SBRA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SBRA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.73
Based on 5.7% avg growth
INTRINSIC VALUE TODAY
$15.36
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $18.73, which is considered slightly low relative to its 30-day fair value range of $18.67 to $19.37. The stock's valuation (Forward PE: 24.7) is in line with its historical norms (25.2). Remarkably, the market is currently pricing in an annual earnings decline of 0.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $18.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.00 (+13.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $18.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.00 (+13.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$18.67 -
$19.37
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($21.00)
Fair Price Analysis
30-Day Fair Range
$18.67 -
$19.37
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$18.32
Resistance Level
$19.47
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
24.69
Wall Street Target
$21.00
(+13.4%)
Revenue Growth (YoY)
7.3%
Earnings Growth (YoY)
-29.2%
Profit Margin
23.4%
Valuation Discount vs History
-0.7% cheaper
PE vs Historical
24.7 vs 25.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.7%
(market-implied from PE analysis)
1-Year Target
$18.39
(-1%)
2-Year Target
$18.26
(-1%)
3-Year Target
$18.13
(-2%)
3-Yr Target (if PE normalizes)
(PE: 25→25)
$18.51
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.7, Growth: 7.4%)
$22.97
(+24%)
Base:
(SPY PE: 22.3, Growth: 7.4%)
$20.74
(+12%)
Bear:
(PE: 19.0, Growth: 7.4%)
$17.63
(-5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 25.36 | Current EPS (TTM): $0.73
Bull Case
$20.92
(+13%)
Analyst growth 2.7%, PE expands to 27.9
Base Case
$19.02
(+3%)
Market implied 2.7%, PE stable at 25.4
Bear Case
$12.59
(-32%)
Severe decline -20.0%, PE contracts to 21.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.7 to 25.2
Stabilization Target:
$18.90
(+2.1%)
PE Expansion Potential:
+2.1%
Last updated: January 30, 2026 5:41 PM ET
Data refreshes hourly during market hours. Next update: 6:41 PM
Data refreshes hourly during market hours. Next update: 6:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$86 | 59 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$209 | 62 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$20 | 54 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$14 | 57 HOLD |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$56 | 54 HOLD |
Advanced SBRA Option Strategies
Professional options setups generated by AI based on today's SBRA price and gamma walls.
